An essential role for Smad3 in fibrogenesis is confirmed by the findings that deletion of Smad3 from mice can suppress renal fibrosis in a number of rodent models, including diabetic nephropathy 12, obstructive kidney diseases 13, hypertensive nephropathy 14, and drug-associated nephropathy 15. Here, SMAD3 is linked to hypertensive nephropathy.